You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 3, March 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cataracts/ Lens
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic

Ocular Pathologic Findings of Neurofibromatosis Type 2

Margaret E. McLaughlin, MD; Susan M. Pepin, MD; Mia MacCollin, MD; Pitipol Choopong, MD; Simmons Lessell, MD

Arch Ophthalmol. 2007;125(3):389-394.

Objective  To gain insight into the pathogenesis of neurofibromatosis type 2 (NF2) by investigating the ocular manifestations of this disease.

Methods  Using standard histologic techniques, immunohistochemistry, and electron microscopy, we described the ocular pathologic findings of a 34-year-old woman who died from complications of NF2.

Results  We identified 3 types of NF2-associated lesions: juvenile posterior subcapsular cataracts, epiretinal membranes, and an intrascleral schwannoma.

Conclusions  Our analysis indicated that dysplastic lens cells accumulate just anterior to the posterior lens capsule in juvenile posterior subcapsular cataracts and that dysplastic Müller cells may be a major component of NF2-associated epiretinal membranes.

Clinical Relevance  Our findings suggest that a subset of glial cells with epithelial features (Schwann cells, ependymal cells, and Müller cells) may be particularly sensitive to loss of the NF2 gene. Understanding the molecular basis for this sensitivity may lead to novel strategies for treating NF2.


Author Affiliations: Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, Cambridge (Dr McLaughlin); and Department of Pathology, Brigham and Women's Hospital (Dr McLaughlin), Department of Ophthalmology, Massachusetts Eye and Ear Infirmary (Drs Pepin, Choopong, and Lessell), and Department of Neurology, Massachusetts General Hospital (Dr MacCollin), Boston.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.